• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13D/A filed by Nuvation Bio Inc.

    10/18/24 4:15:55 PM ET
    $NUVB
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $NUVB alert in real time by email
    SC 13D/A 1 d892626dsc13da.htm SC 13D/A SC 13D/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

     

    SCHEDULE 13D

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (Amendment No. 2)*

     

     

    Nuvation Bio, Inc.

    (Name of Issuer)

     

     

    Class A Common Stock

    (Title of Class of Securities)

    67080N 101

    (CUSIP Number)

    OTELLO STAMPACCHIA

    OMEGA FUND V, L.P.

    888 BOYLSTON ST., STE. 1111

    BOSTON, MA 02199

    TELEPHONE: 617-502-6538

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    September 4, 2024

    (Date of Event Which Requires Filing of this Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

     

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

     

     

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 67080N 101   13D

     

     1.   

     Name of Reporting Persons

     

     Omega Fund V, L.P.

     2.  

     Check the Appropriate Box if a Member of a Group (see instructions)

     (a) ☐  (b) ☒(1)

     

     3.  

     SEC USE ONLY

     

     4.  

     Source of Funds (see instructions)

     

     WC

     5.  

     Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

     

     ☐

     6.  

     Citizenship or Place of Organization

     

     Cayman Islands

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

        7.    

     Sole Voting Power

     

     13,072,340 shares of Class A Common Stock (2)

        8.   

     Shared Voting Power

     

     0

        9.   

     Sole Dispositive Power

     

     13,072,340 shares of Class A Common Stock (2)

       10.   

     Shared Dispositive Power

     

     0

    11.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     13,072,340 shares of Class A Common Stock (2)

    12.  

     Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see instructions)

     

     ☐

    13.  

     Percent of Class Represented by Amount in Row 11

     

     3.9% (2)

    14.  

     Type of Reporting Person (see instructions)

     

     PN

     

    (1)

    This Schedule 13D is filed by Omega Fund V, L.P. (“Omega Fund”), Omega Fund V GP, L.P. (“Omega GP”), Omega Fund V GP Manager, Ltd. (“Omega Ltd”), Claudio Nessi (“Nessi”) and Otello Stampacchia (“Stampacchia”) (together, the “Reporting Persons”). Omega Ltd serves as the general partner of Omega GP, which serves as the general partner of Omega Fund; and each of Omega Ltd and Omega GP may be deemed to own beneficially the shares held by Omega Fund. Nessi and Stampacchia are the directors of Omega Ltd and may be deemed to beneficially own the shares held by Omega Fund. The Reporting Persons may be deemed a “group” for purposes of Section 13 of the Exchange Act and expressly disclaim status as a “group” for purposes of this Schedule 13D. Each of Nessi and Stampacchia expressly disclaims beneficial ownership of the securities reported herein, except to the extent of his or her pecuniary interest therein, if any.

    (2)

    This percentage set forth on the cover sheets is calculated based on 333,780,289 shares of Class A Common Stock as of September 4, 2024, as reported in the Issuer’s Current Report on Form 8-K filed with the SEC on September 5, 2024.


    CUSIP No. 67080N 101   13D

     

     1.   

     Name of Reporting Persons

     

     Omega Fund V GP, L.P.

     2.  

     Check the Appropriate Box if a Member of a Group (see instructions)

     (a) ☐  (b) ☒(1)

     

     3.  

     SEC USE ONLY

     

     4.  

     Source of Funds (see instructions)

     

     AF

     5.  

     Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

     

     ☐

     6.  

     Citizenship or Place of Organization

     

     Cayman Islands

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

        7.    

     Sole Voting Power

     

     0

        8.   

     Shared Voting Power

     

     13,072,340 shares of Class A Common Stock (2)

        9.   

     Sole Dispositive Power

     

     0

       10.   

     Shared Dispositive Power

     

     13,072,340 shares of Class A Common Stock (2)

    11.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     13,072,340 shares of Class A Common Stock (2)

    12.  

     Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see instructions)

     

     ☐

    13.  

     Percent of Class Represented by Amount in Row 11

     

     3.9% (2)

    14.  

     Type of Reporting Person (see instructions)

     

     PN

     

    (1)

    This Schedule 13D is filed by Omega Fund V, L.P. (“Omega Fund”), Omega Fund V GP, L.P. (“Omega GP”), Omega Fund V GP Manager, Ltd. (“Omega Ltd”), Claudio Nessi (“Nessi”) and Otello Stampacchia (“Stampacchia”) (together, the “Reporting Persons”). Omega Ltd serves as the general partner of Omega GP, which serves as the general partner of Omega Fund; and each of Omega Ltd and Omega GP may be deemed to own beneficially the shares held by Omega Fund. Nessi and Stampacchia are the directors of Omega Ltd and may be deemed to beneficially own the shares held by Omega Fund. The Reporting Persons may be deemed a “group” for purposes of Section 13 of the Exchange Act and expressly disclaim status as a “group” for purposes of this Schedule 13D. Each of Nessi and Stampacchia expressly disclaims beneficial ownership of the securities reported herein, except to the extent of his or her pecuniary interest therein, if any.

    (2)

    This percentage set forth on the cover sheets is calculated based on 333,780,289 shares of Class A Common Stock as of September 4, 2024, as reported in the Issuer’s Current Report on Form 8-K filed with the SEC on September 5, 2024.


    CUSIP No. 67080N 101   13D

     

     1.   

     Name of Reporting Persons

     

     Omega Fund V GP Manager, Ltd.

     2.  

     Check the Appropriate Box if a Member of a Group (see instructions)

     (a) ☐  (b) ☒(1)

     

     3.  

     SEC USE ONLY

     

     4.  

     Source of Funds (see instructions)

     

     AF

     5.  

     Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

     

     ☐

     6.  

     Citizenship or Place of Organization

     

     Cayman Islands

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

        7.    

     Sole Voting Power

     

     0

        8.   

     Shared Voting Power

     

     13,072,340 shares of Class A Common Stock (2)

        9.   

     Sole Dispositive Power

     

     0

       10.   

     Shared Dispositive Power

     

     13,072,340 shares of Class A Common Stock (2)

    11.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     13,072,340 shares of Class A Common Stock (2)

    12.  

     Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see instructions)

     

     ☐

    13.  

     Percent of Class Represented by Amount in Row 11

     

     3.9% (2)

    14.  

     Type of Reporting Person (see instructions)

     

     OO

     

    (1)

    This Schedule 13D is filed by Omega Fund V, L.P. (“Omega Fund”), Omega Fund V GP, L.P. (“Omega GP”), Omega Fund V GP Manager, Ltd. (“Omega Ltd”), Claudio Nessi (“Nessi”) and Otello Stampacchia (“Stampacchia”) (together, the “Reporting Persons”). Omega Ltd serves as the general partner of Omega GP, which serves as the general partner of Omega Fund; and each of Omega Ltd and Omega GP may be deemed to own beneficially the shares held by Omega Fund. Nessi and Stampacchia are the directors of Omega Ltd and may be deemed to beneficially own the shares held by Omega Fund. The Reporting Persons may be deemed a “group” for purposes of Section 13 of the Exchange Act and expressly disclaim status as a “group” for purposes of this Schedule 13D. Each of Nessi and Stampacchia expressly disclaims beneficial ownership of the securities reported herein, except to the extent of his or her pecuniary interest therein, if any.

    (2)

    This percentage set forth on the cover sheets is calculated based on 333,780,289 shares of Class A Common Stock as of September 4, 2024, as reported in the Issuer’s Current Report on Form 8-K filed with the SEC on September 5, 2024.


    CUSIP No. 67080N 101   13D

     

     

     1.   

     Name of Reporting Persons

     

     Claudio Nessi

     2.  

     Check the Appropriate Box if a Member of a Group (see instructions)

     (a) ☐  (b) ☒(1)

     

     3.  

     SEC USE ONLY

     

     4.  

     Source of Funds (see instructions)

     

     AF

     5.  

     Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

     

     ☐

     6.  

     Citizenship or Place of Organization

     

     Switzerland

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

        7.    

     Sole Voting Power

     

     0

        8.   

     Shared Voting Power

     

     13,072,340 shares of Class A Common Stock (2)

        9.   

     Sole Dispositive Power

     

     0

       10.   

     Shared Dispositive Power

     

     13,072,340 shares of Class A Common Stock (2)

    11.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     13,072,340 shares of Class A Common Stock (2)

    12.  

     Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see instructions)

     

     ☐

    13.  

     Percent of Class Represented by Amount in Row 11

     

     3.9% (2)

    14.  

     Type of Reporting Person (see instructions)

     

     IN

     

    (1)

    This Schedule 13D is filed by Omega Fund V, L.P. (“Omega Fund”), Omega Fund V GP, L.P. (“Omega GP”), Omega Fund V GP Manager, Ltd. (“Omega Ltd”), Claudio Nessi (“Nessi”) and Otello Stampacchia (“Stampacchia”) (together, the “Reporting Persons”). Omega Ltd serves as the general partner of Omega GP, which serves as the general partner of Omega Fund; and each of Omega Ltd and Omega GP may be deemed to own beneficially the shares held by Omega Fund. Nessi and Stampacchia are the directors of Omega Ltd and may be deemed to beneficially own the shares held by Omega Fund. The Reporting Persons may be deemed a “group” for purposes of Section 13 of the Exchange Act and expressly disclaim status as a “group” for purposes of this Schedule 13D. Each of Nessi and Stampacchia expressly disclaims beneficial ownership of the securities reported herein, except to the extent of his or her pecuniary interest therein, if any.

    (2)

    This percentage set forth on the cover sheets is calculated based on 333,780,289 shares of Class A Common Stock as of September 4, 2024, as reported in the Issuer’s Current Report on Form 8-K filed with the SEC on September 5, 2024.


    CUSIP No. 67080N 101   13D

     

     

     1.   

     Name of Reporting Persons

     

     Otello Stampacchia

     2.  

     Check the Appropriate Box if a Member of a Group (see instructions)

     (a) ☐  (b) ☒(1)

     

     3.  

     SEC USE ONLY

     

     4.  

     Source of Funds (see instructions)

     

     AF

     5.  

     Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

     

     ☐

     6.  

     Citizenship or Place of Organization

     

     Italy

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

        7.    

     Sole Voting Power

     

     0

        8.   

     Shared Voting Power

     

     13,072,340 shares of Class A Common Stock (2)

        9.   

     Sole Dispositive Power

     

     0

       10.   

     Shared Dispositive Power

     

     13,072,340 shares of Class A Common Stock (2)

    11.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     13,072,340 shares of Class A Common Stock (2)

    12.  

     Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see instructions)

     

     ☐

    13.  

     Percent of Class Represented by Amount in Row 11

     

     3.9% (2)

    14.  

     Type of Reporting Person (see instructions)

     

     IN

     

    (1)

    This Schedule 13D is filed by Omega Fund V, L.P. (“Omega Fund”), Omega Fund V GP, L.P. (“Omega GP”), Omega Fund V GP Manager, Ltd. (“Omega Ltd”), Claudio Nessi (“Nessi”) and Otello Stampacchia (“Stampacchia”) (together, the “Reporting Persons”). Omega Ltd serves as the general partner of Omega GP, which serves as the general partner of Omega Fund; and each of Omega Ltd and Omega GP may be deemed to own beneficially the shares held by Omega Fund. Nessi and Stampacchia are the directors of Omega Ltd and may be deemed to beneficially own the shares held by Omega Fund. The Reporting Persons may be deemed a “group” for purposes of Section 13 of the Exchange Act and expressly disclaim status as a “group” for purposes of this Schedule 13D. Each of Nessi and Stampacchia expressly disclaims beneficial ownership of the securities reported herein, except to the extent of his or her pecuniary interest therein, if any.

    (2)

    This percentage set forth on the cover sheets is calculated based on 333,780,289 shares of Class A Common Stock as of September 4, 2024, as reported in the Issuer’s Current Report on Form 8-K filed with the SEC on September 5, 2024.


    CUSIP No. 67080N 101   13D

     

    The following constitutes Amendment No. 2 to the Schedule 13D filed by the undersigned (“Amendment No. 2”). This Amendment No. 2 amends the Schedule 13D as specifically set forth herein.

    Item 5. Interest in Securities of the Issuer

    Items 5(a)-(e) are hereby amended and restated to read as follows:

    (a), (b) The aggregate number and percentage of Class A Common Stock of the Issuer owned by each Reporting Person are based upon 333,780,289 shares of Class A Common Stock as of September 4, 2024, as reported in the Issuer’s Current Report on Form 8-K filed with the SEC on September 5, 2024.

    The Reporting Persons may be deemed to beneficially own an aggregate of 13,072,340 shares of Class A Common Stock. This aggregate number represents approximately 3.9% of the total Shares of Class A Common Stock currently outstanding.

    Each Reporting Person may be deemed to beneficially own the shares set forth below:

     

    Omega Fund

         —        13,072,340  

    Omega GP

         —        13,072,340  

    Omega Ltd

         —        13,072,340  

    Nessi

         —        13,072,340  

    Stampacchia

         —        13,072,340  

    The Omega Fund has the sole power to vote and dispose of 13,072,340 Shares of Class A Common Stock as a result of its direct beneficial ownership of 13,072,340 Shares of Class A Common Stock. Omega GP, Omega Ltd, Nessi and Stampacchia may be deemed, on an aggregate basis, to have shared power to vote and dispose of 13,072,340 Shares of Class A Common Stock as a result of their deemed beneficial ownership of 13,072,340 Shares of Class A Common Stock.

    Pursuant to Rule 13d-4 of the Act, each of Nessi and Stampacchia expressly disclaims beneficial ownership of the securities reported herein, except to the extent of his or her pecuniary interest therein, if any.

    (c) Information concerning transactions in the shares of Class A Common Stock effected within last 60 days by the Reporting Persons is set forth below.

     

    Reporting Person Who Effected The Transaction

       Date of
    Transaction
         Number
    of Shares
         Type of
    Security
       Average Price
    Per Share
         Where and How
    the Transaction
    was Effected

    Omega Fund

         07/12/2024        85,082      Class A
    Common Stock
       $ 3.5112      Open market
    sale on Nasdaq

    Omega Fund

         07/16/2024        8,493      Class A
    Common Stock
       $ 3.5000      Open market
    sale on Nasdaq

    Omega Fund

         07/24/2024        109,929      Class A
    Common Stock
       $ 3.5551      Open market
    sale on Nasdaq

    (d) Not applicable.

    (e) As of September 4, 2024, the Reporting Persons ceased to be beneficial owners of more than five percent of the Issuer’s Class A Common Stock.


    CUSIP No. 67080N 101   13D

     

    SIGNATURES

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: October 18, 2024

     

    OMEGA FUND V, L.P.
    BY: Omega Fund V GP, L.P.
    ITS: GENERAL PARTNER
    BY: Omega Fund V GP Manager, Ltd.
    ITS: GENERAL PARTNER
    By:  

    /s/ * Deirdre A. Cunnane, as Attorney-in-Fact

      Director
    OMEGA FUND V GP, L.P.
    BY: Omega Fund V GP Manager, Ltd.
    ITS: GENERAL PARTNER
    By:  

    /s/ * Deirdre A. Cunnane, as Attorney-in-Fact

      Director
    OMEGA FUND V GP MANAGER, LTD.
    By:  

    /s/ * Deirdre A. Cunnane, as Attorney-in-Fact

      Director

    /s/ * Deirdre A. Cunnane, as Attorney-in-Fact

    Claudio Nessi

    /s/ * Deirdre A. Cunnane, as Attorney-in-Fact

    Otello Stampacchia
    Get the next $NUVB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NUVB

    DatePrice TargetRatingAnalyst
    4/23/2025$6.00Mkt Outperform
    Citizens JMP
    3/27/2024$1.40 → $10.00Hold → Buy
    Jefferies
    3/26/2024$5.00Neutral → Buy
    BTIG Research
    1/6/2023$5.00 → $2.00Buy → Hold
    Jefferies
    8/2/2022$8.00 → $2.50Outperform → Market Perform
    BMO Capital Markets
    8/2/2022Buy → Neutral
    BTIG Research
    5/4/2022$14.00Buy
    H.C. Wainwright
    10/15/2021$16.00Buy
    BTIG Research
    More analyst ratings